She plans to use the funds to develop new surveillance and diagnostic strategies for immunotherapy trials
Aug. 8, 2018
| By Colin Petersdorf / Fred Hutch News Service
Fred Hutchinson Cancer Research Center biostatistician Dr. Yingqi Zhao has been awarded the Dr. Charles A. Coltman Jr. Fellowship, which recognizes and funds prolific early- and mid-career scientists from affiliated institutions within SWOG, a national clinical trials network.
Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss
March 21, 2018
| By Diane Mapes / Fred Hutch News Service
Fred Hutch public health researcher Dr. Joe Unger used an innovative trial design to confirm finasteride, a drug used to treat enlarged prostate or hair loss in men, has a long-term protective effect against prostate cancer.
Adult survivors of childhood cancer suffer from ‘financial toxicity’ decades later, a study conducted at the dawn of the Affordable Care Act found
Sept. 26, 2017
| By Rachel Tompa / Fred Hutch News Service
Before the Affordable Care Act's rollout, adult survivors of childhood cancer were more likely to be denied health care coverage than those without a history of cancer, paid more out-of-pocket and were more likely to borrow money to pay their medical bills, a new study has found.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.